GeneDx Holdings Corp. (WGS) Free Cash Flow
GeneDx Holdings Corp. (WGS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$117.22M |
| 2021-12-31 | -$211.22M |
| 2022-12-31 | -$333.48M |
| 2023-12-31 | -$185.86M |
| 2024-12-31 | -$33.99M |
| 2025-12-31 | $14.26M |
How WGS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ARRY | Array Technologies Inc. | $79.81M |
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| TGTX | TG Therapeutics Inc. | -$24.99M |
| TRVI | Trevi Therapeutics Inc. | -$42.10M |
| ACRS | Aclaris Therapeutics Inc. | -$47.22M |
These are five companies in the same sector as WGS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get GeneDx Holdings Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("WGS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | WGS | $87.06 | +5.47% | 0.56M |
| 3 | ||||
| 4 | ||||
| 5 |